Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» downgrades
downgrades
Is Dendreon's Downgrade Deserved?
Motley Fool
Wed, 05/30/12 - 10:20 am
Dendreon
downgrades
Provenge
prostate cancer
JNJ
Zytiga
FDA Final Rule: TearScience's LipiFlow eyelid thermal pulsation downgraded to Class II
Sat, 08/20/11 - 12:00 am
FDA
TearScience
eye
downgrades
Impax drops 11% on downgrade
Marketwatch
Wed, 06/8/11 - 10:48 am
downgrades
Impax
Ahead of the Bell: Analyst lowers Bristol-Myers
Yahoo/AP
Thu, 03/31/11 - 10:41 am
Bristol-Myers Squibb
downgrades
GlaxoSmithKline - Upgrades & Downgrades
TheStreet.com
Mon, 10/25/10 - 10:52 am
GSK
analysts
downgrades
upgrades
Gilead: Analysts' Upgrades, Downgrades
TheStreet.com
Mon, 08/16/10 - 10:05 am
downgrades
upgrades
Gilead Sciences
Analyst downgrades Medtronic on device headwinds
Mon, 08/9/10 - 02:25 pm
downgrades
Medtronic
JNJ
Vivus slides after analyst downgrades to 'Sell'
Yahoo/AP
Tue, 08/3/10 - 07:01 pm
Vivus
downgrades
obesity
Qnexa
Orexigen
Contrave
Arena Pharmaceuticals
Enzon Pharmaceuticals shares fall on downgrade
Yahoo/AP
Wed, 06/30/10 - 08:54 am
Enzon
downgrades
Brean Murray Carret analyst downgrades Intuitive Surgical on European sales concerns
Mon, 06/14/10 - 02:57 pm
downgrades
Intuitive Surgical
Conmed Downgraded
Thu, 06/3/10 - 09:05 pm
Conmed
downgrades
Smith & Nephew
Stryker
Credit Suisse downgrades GlaxoSmithKline
Marketwatch
Wed, 01/13/10 - 09:35 am
GSK
downgrades
Moody's downgrades Pfizer on Wyeth acquisition
Marketwatch
Thu, 10/15/09 - 04:02 pm
downgrades
Pfizer
Wyeth
M&A
Analyst thinks sales of Arena's lorcaserin will trail other obesity drugs, downgrades stock
Yahoo/AP
Wed, 09/16/09 - 09:11 am
downgrades
Arena Pharmaceuticals
obesity
lorcaserin
Vivus
Orexigen
GlaxoSmithKline cut at SocGen on threat to Advair
Marketwatch
Thu, 09/10/09 - 08:49 am
GSK
Advair
downgrades
generics
Bristol-Myers Squibb downgraded on share price
Business Insider
Fri, 08/28/09 - 12:05 pm
Bristol-Myers Squibb
downgrades
Analysts downgrades Celgene due to higher price and questions about expectations for Revlimid
Yahoo/AP
Thu, 08/6/09 - 01:45 pm
Celgene
downgrades
Revlimid